Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | PPARD | Q03181 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10590583 | 0.81 | TSHR (0.41) | TSHRTP53TDP1PPARDALDH1A1 | |
| SCHEMBL7921583 | 0.80 | MAPT (0.37) | TSHRALDH1A1 | |
| SCHEMBL14105288 | 0.78 | TSHR (0.40) | TSHRTP53TDP1PPARDALDH1A1 | |
| SCHEMBL905270 | 0.78 | TSHR (0.36) | TSHRTP53TDP1PPARDSMN1; SMN2 | |
| SCHEMBL7490235 | 0.75 | TSHR (0.37) | TSHRTP53TDP1PPARDSMN1; SMN2 | |
| SCHEMBL10128271 | 0.75 | TSHR (0.46) | TSHRTP53TDP1PPARDALDH1A1 | |
| SCHEMBL17355672 | 0.74 | TSHR (0.40) | TSHRTP53TDP1PPARDALDH1A1 | |
| SCHEMBL1683252 | 0.73 | TSHR (0.32) | TSHRTP53TDP1PPARDSMN1; SMN2 | |
| Propene SCHEMBL28006038 | 0.73 | TSHR (0.34) | TSHRTP53TDP1PPARDCA12 | |
| SCHEMBL2079486 | 0.72 | TSHR (0.39) | TSHRTP53TDP1PPARDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8962192-B2 | Nonaqueous electrolytic solution and nonaqueous electrolyte battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2015-02-24 | — | — | US | disclosed |
| CN-101291903-B | Novel unsaturated fatty hydroxy acid derivatives and the dermocosmetologic use thereof | FABRE PIERRE DERMO COSMETIQUE | 2014-09-10 | — | — | CN | disclosed |
| US-8574757-B2 | Nonaqueous electrolytic solution and nonaqueous electrolyte battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-11-05 | — | — | US | disclosed |
| US-20120264011-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-10-18 | — | — | US | disclosed |
| US-8158811-B2 | Unsaturated fatty hydroxy acid derivatives and the dermocosmetologic use thereof | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2012-04-17 | — | — | US | disclosed |
| US-7928254-B2 | Method for preparing unsaturated fatty hydroxyacids | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2011-04-19 | — | — | US | disclosed |
| US-20100035147-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2010-02-11 | — | — | US | disclosed |
| US-20090238784-A1 | Novel Unsaturated Fatty Hydroxy Acid Derivatives and the Dermocosmetologic Use Thereof | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2009-09-24 | — | — | US | disclosed |
| US-20080281114-A1 | Novel Method for Preparing Unsaturated Fatty Hydroxyacids | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2008-11-13 | — | — | US | disclosed |
| CN-101291903-A | Novel unsaturated fatty hydroxy acid derivatives and the dermocosmetologic use thereof | FABRE PIERRE DERMO COSMETIQUE (FR) | 2008-10-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090238784-A1 | Novel Unsaturated Fatty Hydroxy Acid Derivatives and the Dermocosmetologic Use Thereof | ELOVL3, FFAR3, FASN | TSHR 1800/4885TP53 4175/4885TDP1 4771/4885 |
| US-20080281114-A1 | Novel Method for Preparing Unsaturated Fatty Hydroxyacids | FASN, ELOVL1, ELOVL3 | TSHR 3172/4885TP53 4330/4885TDP1 4697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.